Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aryeh Fischer

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Chest|April 30, 2018
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY TrialKelly M Chin, Mardi Gomberg-Maitland, Richard N Channick, et al.
BMJ Open Respiratory Research|December 31, 2021
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.
Rheumatology (Oxford, England)|April 24, 2025
Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)Rohit Aggarwal, Nantakarn Pongtarakulpanit, Daniel I Sullivan, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
The European Respiratory Journal|November 21, 2015
Predictors of mortality in rheumatoid arthritis-associated interstitial lung diseaseJoshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Seminars in Arthritis and Rheumatism|April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort studyVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2017
Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis PatientsM Kristen Demoruelle, Kylie K Harrall, Linh Ho, et al.
Respiratory Medicine|April 17, 2012
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue diseaseAryeh Fischer, Joshua J Solomon, Roland M du Bois, et al.
Arthritis Care & Research|August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registryLorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Chest|April 30, 2018
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY TrialKelly M Chin, Mardi Gomberg-Maitland, Richard N Channick, et al.
BMJ Open Respiratory Research|December 31, 2021
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.
Rheumatology (Oxford, England)|April 24, 2025
Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)Rohit Aggarwal, Nantakarn Pongtarakulpanit, Daniel I Sullivan, et al.
Annals of the Rheumatic Diseases|February 7, 2012
Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registrySangmee Bae, Rajeev Saggar, Marcy B Bolster, et al.
The European Respiratory Journal|November 21, 2015
Predictors of mortality in rheumatoid arthritis-associated interstitial lung diseaseJoshua J Solomon, Jonathan H Chung, Gregory P Cosgrove, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Seminars in Arthritis and Rheumatism|April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort studyVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2017
Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis PatientsM Kristen Demoruelle, Kylie K Harrall, Linh Ho, et al.
Respiratory Medicine|April 17, 2012
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue diseaseAryeh Fischer, Joshua J Solomon, Roland M du Bois, et al.
Arthritis Care & Research|August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registryLorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Pageof 11